| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773743 | Kidney International Reports | 2018 | 11 Pages |
Abstract
These data demonstrated plasma proteome dysregulation in renally impaired patients and the beneficial impact of apabetalone on pathways linked to chronic kidney disease and its cardiovascular complications.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sylwia Wasiak, Laura M. Tsujikawa, Christopher Halliday, Stephanie C. Stotz, Dean Gilham, Ravi Jahagirdar, Kamyar Kalantar-Zadeh, Richard Robson, Michael Sweeney, Jan O. Johansson, Norman C. Wong, Ewelina Kulikowski,